ASLAN Pharmaceuticals Ltd

CIK 1722926 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ASLAN Pharmaceuticals Ltd.

Recent SEC filings

FiledFormAccession number
Nov 14, 2024SC 13G0000929638-24-003916
Nov 14, 2024SC 13G/A0001140361-24-046893
Sep 6, 202425-NSE0001354457-24-000656
Aug 8, 2024SCHEDULE 13G/A0001610520-24-000138
Jul 17, 20246-K0000950170-24-084064
Jul 15, 20246-K0000950170-24-083384
Jun 21, 2024EFFECT9999999995-24-001915
Jun 14, 2024F-6 POS0001193805-24-000805
Jun 14, 20246-K0001193125-24-161691
Jun 12, 2024F-30001193125-24-159983
May 31, 20246-K0000950170-24-067347
May 9, 20246-K0000950170-24-056267
May 7, 20246-K0000950170-24-053953
Apr 22, 20246-K0000950170-24-046201
Apr 19, 20246-K0001193125-24-103019
Apr 12, 202420-F0000950170-24-043860
Apr 12, 20246-K0000950170-24-043871
Apr 12, 20246-K0000950170-24-043852
Apr 12, 2024S-80000950170-24-043862
Apr 12, 2024424B50000950170-24-043873
Mar 29, 2024EFFECT9999999995-24-000801
Mar 28, 2024D0001722926-24-000001
Mar 25, 2024F-30001193125-24-076568
Mar 21, 2024SC 13G0001213900-24-024796
Mar 19, 2024SC 13G0000929638-24-001052